CA
Cetera Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $6.08M | Buy |
44,335
+32,025
| +260% | +$4.39M | 0.05% | 388 |
|
2023
Q4 | $1.67M | Sell |
12,310
-432
| -3% | -$58.7K | 0.02% | 567 |
|
2023
Q3 | $1.56M | Sell |
12,742
-595
| -4% | -$72.8K | 0.02% | 554 |
|
2023
Q2 | $1.69M | Sell |
13,337
-598
| -4% | -$75.9K | 0.03% | 522 |
|
2023
Q1 | $1.8M | Sell |
13,935
-18,211
| -57% | -$2.35M | 0.03% | 485 |
|
2022
Q4 | $4.22M | Buy |
32,146
+1,959
| +6% | +$257K | 0.08% | 269 |
|
2022
Q3 | $3.53M | Buy |
30,187
+15,132
| +101% | +$1.77M | 0.09% | 230 |
|
2022
Q2 | $1.77M | Sell |
15,055
-1,172
| -7% | -$138K | 0.04% | 415 |
|
2022
Q1 | $2.11M | Buy |
16,227
+850
| +6% | +$111K | 0.04% | 399 |
|
2021
Q4 | $2.35M | Sell |
15,377
-3,796
| -20% | -$579K | 0.05% | 358 |
|
2021
Q3 | $3.1M | Buy |
19,173
+1,514
| +9% | +$245K | 0.06% | 309 |
|
2021
Q2 | $2.89M | Buy |
17,659
+276
| +2% | +$45.2K | 0.07% | 289 |
|
2021
Q1 | $2.62M | Sell |
17,383
-2,186
| -11% | -$329K | 0.07% | 264 |
|
2020
Q4 | $2.96M | Sell |
19,569
-332
| -2% | -$50.3K | 0.1% | 203 |
|
2020
Q3 | $2.7M | Buy |
19,901
+1,399
| +8% | +$189K | 0.1% | 186 |
|
2020
Q2 | $2.53M | Sell |
18,502
-4,812
| -21% | -$658K | 0.11% | 191 |
|
2020
Q1 | $2.51M | Buy |
23,314
+9,167
| +65% | +$988K | 0.13% | 166 |
|
2019
Q4 | $1.7M | Sell |
14,147
-17,039
| -55% | -$2.05M | 0.07% | 262 |
|
2019
Q3 | $3.1M | Sell |
31,186
-13,637
| -30% | -$1.36M | 0.14% | 151 |
|
2019
Q2 | $4.88M | Buy |
44,823
+1,469
| +3% | +$160K | 0.22% | 108 |
|
2019
Q1 | $4.85M | Sell |
43,354
-17,833
| -29% | -$1.99M | 0.24% | 97 |
|
2018
Q4 | $5.9M | Buy |
61,187
+20,412
| +50% | +$1.97M | 0.34% | 66 |
|
2018
Q3 | $4.97M | Sell |
40,775
-8,133
| -17% | -$991K | 0.24% | 94 |
|
2018
Q2 | $5.37M | Sell |
48,908
-2,389
| -5% | -$262K | 0.31% | 70 |
|
2018
Q1 | $5.48M | Buy |
51,297
+15,500
| +43% | +$1.65M | 0.33% | 73 |
|
2017
Q4 | $3.82M | Buy |
35,797
+24,648
| +221% | +$251K | 0.23% | 97 |
|
2017
Q3 | $3.72M | Buy |
11,149
+303
| +3% | +$101K | 0.22% | 108 |
|
2017
Q2 | $3.37M | Sell |
10,846
-6,167
| -36% | -$1.92M | 0.21% | 114 |
|
2017
Q1 | $4.98M | Buy |
17,013
+611
| +4% | +$179K | 0.33% | 65 |
|
2016
Q4 | $4.36M | Buy |
16,402
+6,956
| +74% | +$1.85M | 0.33% | 67 |
|
2016
Q3 | $2.73M | Buy |
9,446
+1,695
| +22% | +$489K | 0.21% | 109 |
|
2016
Q2 | $2M | Sell |
7,751
-105
| -1% | -$27.1K | 0.16% | 148 |
|
2016
Q1 | $2.06M | Buy |
7,856
+1,275
| +19% | +$334K | 0.17% | 144 |
|
2015
Q4 | $2.22M | Buy |
6,581
+125
| +2% | +$42.2K | 0.19% | 131 |
|
2015
Q3 | $1.96M | Buy |
6,456
+585
| +10% | +$178K | 0.19% | 143 |
|
2015
Q2 | $2.16M | Buy |
5,871
+1,363
| +30% | +$502K | 0.18% | 140 |
|
2015
Q1 | $1.55M | Sell |
4,508
-1,978
| -30% | -$680K | 0.14% | 170 |
|
2014
Q4 | $1.97M | Buy |
6,486
+671
| +12% | +$203K | 0.19% | 132 |
|
2014
Q3 | $1.59M | Sell |
5,815
-2,459
| -30% | -$672K | 0.12% | 149 |
|
2014
Q2 | $2.13M | Sell |
8,274
-4,391
| -35% | -$1.13M | 0.24% | 108 |
|
2014
Q1 | $2.99M | Buy |
12,665
+3,860
| +44% | +$912K | 0.41% | 50 |
|
2013
Q4 | $2M | Sell |
8,805
-955
| -10% | -$217K | 0.3% | 85 |
|
2013
Q3 | $2.04M | Buy |
9,760
+4
| +0% | +$836 | 0.36% | 65 |
|
2013
Q2 | $1.7M | Buy |
+9,756
| New | +$1.7M | 0.35% | 68 |
|